Antiretroviral Franchise
Through its Matrix subsidiary, Mylan is one of the world’s largest suppliers of the active pharmaceutical ingredients used to
make generic antiretroviral (ARV) products, which treat people living with HIV/AIDS. The company also maintains an impressive
portfolio of finished dosage forms of ARVs, including pediatric therapies. The hallmark of Mylan’s ARV franchise to date is
affordability, as it has continually and significantly reduced drug costs. As a result, the company’s ARV products are helping nearly
one-third of all people receiving treatment today for HIV/AIDS in the developing world. The company intends to build on this
achievement by introducing innovations that expand people’s access to ARV medications and related resources. To view our ARV Brochure
(September 2009) and download or print copies by clicking the image below.